Is a therapeutic dengue monoclonal antibody on the way?

Ooi, Eng Eong; Chan, Yvonne Fz

Ooi, Eng Eong; Chan, Yvonne Fz.

Afiliação

Ooi EE; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore; Department of Translational Clinical Research, Singapore General Hospital, Singapore; Saw Swee Hock School of Public Health, National University of Singapore, Singapore. Electronic address: engeong.ooi@duke-nus.edu.sg.
Chan YF; Department of Infectious Diseases, Singapore General Hospital, Singapore.

Lancet Infect Dis ; 24(6): 567-568, 2024 Jun.

Article em En | MEDLINE | ID: mdl-38408456

Assuntos

Anticorpos Monoclonais; Anticorpos Antivirais; Vírus da Dengue; Dengue; Humanos; Anticorpos Monoclonais/uso terapêutico; Dengue/imunologia; Dengue/tratamento farmacológico; Anticorpos Antivirais/uso terapêutico; Vírus da Dengue/imunologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Dengue / Vírus da Dengue / Anticorpos Monoclonais / Anticorpos Antivirais Limite: Humans Idioma: En Revista: Lancet Infect Dis Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google